Most Recent Episode
We Just Built a $1.5B Biologics Company… And We're Here to Disrupt the Industry - Joon Chang What does it really take to build credibility as a new CDMO in a highly competitive biologics market, while staying grounded in patient impact?
This week on Making It In Manufacturing, Harry Sloan sat down with Joon Chang, Chief Business Officer at Lott
Time: 18:23
What does it really take to build credibility as a new CDMO in a highly competitive biologics market, while staying grounded in patient impact?
This week on Making It In Manufacturing, Harry Sloan sat down with Joon Chang, Chief Business Officer at Lotte Biologics, with years of experience spanning Pharma, CDMO, project management, and business development roles across global organisations.
In this episode, Joon Chang covers:
• (02:17) Building credibility as a new CDMO and overcoming the challenge of limited track record while leveraging experienced talent from legacy manufacturing sites
• (03:05) Why people and expertise matter more than company age when delivering successful tech transfer, development, and manufacturing outcomes
• (04:17) The importance of tailoring partnerships to individual client needs and building long-term relationships across Pharma and biotech organisations
• (07:00) Career journey from bench scientist to commercial leadership, and how experience across Pharma and CDMO environments shapes client-centric thinking
• (10:10) Creating a patient-centric culture in manufacturing and commercial teams, and why connecting daily operations to patient impact strengthens partnerships
If you are interested in how emerging CDMOs can differentiate themselves through culture, capability, and client alignment, this episode offers a grounded and practical perspective worth your time.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: https://open.spotify.com/show/0kEcRZOiJChOoN1KF2n1ng
Instagram: https://www.instagram.com/arto.talent?igsh=MWdhbWl5N204a253NQ%3D%3D&utm_source=qr
TikTok: https://www.tiktok.com/@artotalent?_t=ZG-8tHbGACAZaj&_r=1
Apple Podcasts: https://podcasts.apple.com/us/podcast/leading-beyond-the-lab/id1783115575
Website: https://arto-talent.com/
Youtube: https://www.youtube.com/@life_sciences
Joon Chang
LinkedIn: https://www.linkedin.com/in/joon-chang-a337895/
Harry Sloan
LinkedIn: https://www.linkedin.com/in/harry-sloan-605620154/
Timestamps:
00:00 Introduction at the DCAT Conference
00:33 Overview of Lotte Biologics and market positioning
01:20 Capabilities in biologics manufacturing and conjugation
02:01 Challenges of entering the CDMO market as a new player
03:05 Importance of talent and retained expertise from legacy sites
03:52 Building relationships with Pharma and biotech clients
04:24 Dual hub model across the US and South Korea
05:01 Manufacturing scale advantages and commercial readiness
06:19 Speed, cost efficiency, and internal tech transfer benefits
07:00 Career journey from Pharma to CDMO leadership
08:04 Understanding client mindset from both Pharma and CDMO perspectives
08:54 Project management experience and client relationship ownership
09:43 Leadership philosophy and full lifecycle thinking
10:10 Building an ideal organisational culture
10:40 Patient-centric approach and ultra-rare disease considerations
11:43 Connecting operations to patient impact
12:34 Applying culture to commercial and sales teams
13:21 Business development mission and value creation
13:40 Leadership approach and empowering teams
15:00 Vision for disrupting the CDMO industry
16:21 Growth, partnerships, and expanding patient reach
17:01 Personal motivation and purpose behind the work
18:00 Team culture and collaboration
#MakingItInManufacturing #ARTOTalent #Biologics #CDMO #Pharma #Biotech #Manufacturing
Hosted on Acast. See acast.com/privacy for more information.
GUID: 69f08a3d7beb8128694a26a7
Release Date: 28/04/2026, 11:25:43
